HLA Demographics Study in Adults With Type 1 Diabetes

Recruiting Observational Study
Diabetes Mellitus, Type I
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 55
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
GentiBio, Inc · Industry
Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male and female participants aged ≥ 18 to ≤ 55 years, with type 1 DM meeting American Diabetes Association criteria at diagnosis: 1. Fasting glucose ≥ 126 mg/dL (7.0 mmol/L), or 2. 2-hour oral glucose tolerance test plasma glucose ≥ 200 mg/dL (11.0 mmol/L), or 3. He…
Contacts

Kristin M Neff, MS

85-732-75483

kristin.neff@gentibio.com

CONTACT

Mark Bach, MD

908-578-3634

mark.bach@gentibio.com

CONTACT